The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B
Background and Aim. miRNAs play an important role in the development of human fibrosis. However, miRNA expression profiles during different stages of chronic hepatitis B (CHB) are not well defined. In this study, we aimed to further validate the features of 5 miRNA candidates from our previous study...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2021/6636947 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832559766824550400 |
|---|---|
| author | Qingqing Zhang Qidi Zhang Binghang Li Ying Qu Zhenghong Li Lungen Lu Rongzhou Li Xiaobo Cai |
| author_facet | Qingqing Zhang Qidi Zhang Binghang Li Ying Qu Zhenghong Li Lungen Lu Rongzhou Li Xiaobo Cai |
| author_sort | Qingqing Zhang |
| collection | DOAJ |
| description | Background and Aim. miRNAs play an important role in the development of human fibrosis. However, miRNA expression profiles during different stages of chronic hepatitis B (CHB) are not well defined. In this study, we aimed to further validate the features of 5 miRNA candidates from our previous study during different fibrotic stages and the value of diagnosis for liver fibrosis. Methods. Differential expression of five selected miRNAs (hsa-mir-1225-3p, hsa-mir-1238, hsa-miR-3162-3P, hsa-miR-4721, and hsa-miR-H7) was verified by qRT-PCR in the plasma of 83 patients and 20 healthy controls. The relative expression of these miRNAs was analyzed in different groups to screen target miRNA. A logistic regression analysis was performed to assess factors associated with fibrosis progression. The receiver operating characteristic (ROC) curve and discriminant analyses validated the ability of these predicted variables to discriminate the nonsignificant liver fibrosis group from the significant liver fibrosis group. Furthermore, the established models were compared with other prediction models to evaluate the diagnostic efficiency. Results. These five tested miRNAs all had signature correlations with hepatic fibrotic level (p<0.05), and the upregulation trends were consistent with miRNA microarray analysis previously. The multivariate logistic regression analysis identified that a model of five miRNAs (miR-5) had a high diagnostic accuracy in discrimination of different stages of liver fibrosis. The ROC showed that the miR-5 has excellent value in diagnosis of fibrosis, even better than the Forns score, FIB-4, S index, and APRI. GO functions of different miRNAs mainly involved in various biological processes were markedly involved in HBV and revealed signaling pathways dysregulated in liver fibrosis of CHB patients. Conclusions. It was validated that the combination of these five miRNAs was a new set of promising molecular diagnostic markers for liver fibrosis. The diagnosis model (miR-5) can distinguish significant and nonsignificant liver fibrosis with high sensitivity and specificity. |
| format | Article |
| id | doaj-art-5e66ea5afbde454789003e95b3783d8e |
| institution | Kabale University |
| issn | 0962-9351 1466-1861 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Mediators of Inflammation |
| spelling | doaj-art-5e66ea5afbde454789003e95b3783d8e2025-02-03T01:29:21ZengWileyMediators of Inflammation0962-93511466-18612021-01-01202110.1155/2021/66369476636947The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis BQingqing Zhang0Qidi Zhang1Binghang Li2Ying Qu3Zhenghong Li4Lungen Lu5Rongzhou Li6Xiaobo Cai7Department of Gastroenterology, Ruian People’s Hospital, Wenzhou, Zhejiang Province 325200, ChinaDepartment of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, ChinaDepartment of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, ChinaDepartment of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, ChinaDepartment of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, ChinaDepartment of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, ChinaDepartment of Gastroenterology, Ruian People’s Hospital, Wenzhou, Zhejiang Province 325200, ChinaDepartment of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, ChinaBackground and Aim. miRNAs play an important role in the development of human fibrosis. However, miRNA expression profiles during different stages of chronic hepatitis B (CHB) are not well defined. In this study, we aimed to further validate the features of 5 miRNA candidates from our previous study during different fibrotic stages and the value of diagnosis for liver fibrosis. Methods. Differential expression of five selected miRNAs (hsa-mir-1225-3p, hsa-mir-1238, hsa-miR-3162-3P, hsa-miR-4721, and hsa-miR-H7) was verified by qRT-PCR in the plasma of 83 patients and 20 healthy controls. The relative expression of these miRNAs was analyzed in different groups to screen target miRNA. A logistic regression analysis was performed to assess factors associated with fibrosis progression. The receiver operating characteristic (ROC) curve and discriminant analyses validated the ability of these predicted variables to discriminate the nonsignificant liver fibrosis group from the significant liver fibrosis group. Furthermore, the established models were compared with other prediction models to evaluate the diagnostic efficiency. Results. These five tested miRNAs all had signature correlations with hepatic fibrotic level (p<0.05), and the upregulation trends were consistent with miRNA microarray analysis previously. The multivariate logistic regression analysis identified that a model of five miRNAs (miR-5) had a high diagnostic accuracy in discrimination of different stages of liver fibrosis. The ROC showed that the miR-5 has excellent value in diagnosis of fibrosis, even better than the Forns score, FIB-4, S index, and APRI. GO functions of different miRNAs mainly involved in various biological processes were markedly involved in HBV and revealed signaling pathways dysregulated in liver fibrosis of CHB patients. Conclusions. It was validated that the combination of these five miRNAs was a new set of promising molecular diagnostic markers for liver fibrosis. The diagnosis model (miR-5) can distinguish significant and nonsignificant liver fibrosis with high sensitivity and specificity.http://dx.doi.org/10.1155/2021/6636947 |
| spellingShingle | Qingqing Zhang Qidi Zhang Binghang Li Ying Qu Zhenghong Li Lungen Lu Rongzhou Li Xiaobo Cai The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B Mediators of Inflammation |
| title | The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B |
| title_full | The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B |
| title_fullStr | The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B |
| title_full_unstemmed | The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B |
| title_short | The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B |
| title_sort | diagnosis value of a novel model with 5 circulating mirnas for liver fibrosis in patients with chronic hepatitis b |
| url | http://dx.doi.org/10.1155/2021/6636947 |
| work_keys_str_mv | AT qingqingzhang thediagnosisvalueofanovelmodelwith5circulatingmirnasforliverfibrosisinpatientswithchronichepatitisb AT qidizhang thediagnosisvalueofanovelmodelwith5circulatingmirnasforliverfibrosisinpatientswithchronichepatitisb AT binghangli thediagnosisvalueofanovelmodelwith5circulatingmirnasforliverfibrosisinpatientswithchronichepatitisb AT yingqu thediagnosisvalueofanovelmodelwith5circulatingmirnasforliverfibrosisinpatientswithchronichepatitisb AT zhenghongli thediagnosisvalueofanovelmodelwith5circulatingmirnasforliverfibrosisinpatientswithchronichepatitisb AT lungenlu thediagnosisvalueofanovelmodelwith5circulatingmirnasforliverfibrosisinpatientswithchronichepatitisb AT rongzhouli thediagnosisvalueofanovelmodelwith5circulatingmirnasforliverfibrosisinpatientswithchronichepatitisb AT xiaobocai thediagnosisvalueofanovelmodelwith5circulatingmirnasforliverfibrosisinpatientswithchronichepatitisb AT qingqingzhang diagnosisvalueofanovelmodelwith5circulatingmirnasforliverfibrosisinpatientswithchronichepatitisb AT qidizhang diagnosisvalueofanovelmodelwith5circulatingmirnasforliverfibrosisinpatientswithchronichepatitisb AT binghangli diagnosisvalueofanovelmodelwith5circulatingmirnasforliverfibrosisinpatientswithchronichepatitisb AT yingqu diagnosisvalueofanovelmodelwith5circulatingmirnasforliverfibrosisinpatientswithchronichepatitisb AT zhenghongli diagnosisvalueofanovelmodelwith5circulatingmirnasforliverfibrosisinpatientswithchronichepatitisb AT lungenlu diagnosisvalueofanovelmodelwith5circulatingmirnasforliverfibrosisinpatientswithchronichepatitisb AT rongzhouli diagnosisvalueofanovelmodelwith5circulatingmirnasforliverfibrosisinpatientswithchronichepatitisb AT xiaobocai diagnosisvalueofanovelmodelwith5circulatingmirnasforliverfibrosisinpatientswithchronichepatitisb |